Trending Topic

5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

touchDERMATOLOGY coverage from EADV 2024: Twice-daily continuous application of ruxolitinib cream, a topical selective JAK1/JAK2 inhibitor, has been reported to be safe and effective in treating children with mild to moderate atopic dermatitis (AD) over an 8-week period in the TRuE-AD studies.1,2 In this interview, we talk with Dr Amy Paller from the Northwestern University […]

Your free ‘10 minutes at a time’ medical education

Join a global community of thousands of healthcare professionals improving patient outcomes with FREE access to our mobile-optimised medical education platform. Discover the latest science delivered concisely so you can learn from anywhere at a pace to suit you.

Sign up today and get immediate access to:

  • 1000’s topical and insightful peer-reviewed journal articles
  • 100’s hours of bite-sized congress highlights from renowned key opinion leaders
  • 8 major therapy areas packed with the latest scientific advances
  • 150+ specialities offering learn-on-the-go medical education
  • Concise email updates and newsletters so you never miss out

It only takes a minute to register and it’s free (forever) to all healthcare professionals.

touchDERMATOLOGY touchDERMATOLOGY

Register Now!

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

  • Save your progress for video
  • Keep track of your CME credits
  • Add personalised learning notes
  • Receive updates from course leaders and faculty
  • Be the first to hear about new and exciting interactive learning opportunities
Close Popup